Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr Timothy Coté joins NORD as CMO

This article was originally published in Scrip

Executive Summary

Dr Timothy Coté has been appointed chief medical officer of the National Organization for Rare Disorders in the US, having served as director of the Food and Drug Administration's Office of Orphan Products Development between 2007 and May 2011. Dr Coté's new role will be to provide medical guidance in all areas – particularly advocacy and education – to promote fair, compassionate public policies; encourage the development of safe, effective treatments; and increase awareness of rare diseases and the needs of patients and their families.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC013792

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel